LLA.L,0P0001T9GN,0 Share · USU5500L1128 (XLON) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of LLA.L,0P0001T9GN,0
No Price
Company Profile for LLA.L,0P0001T9GN,0 Share
LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.
Company Data
Name LLA.L,0P0001T9GN,0
Company LungLife AI, Inc.
Website
https://lunglifeai.com
Primary Exchange 
London
London
ISIN USU5500L1128
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Paul Pagano
Country United States of America
Currency GBX
Employees 0,0 T
Address 2545 West Hillcrest Drive, 91320 Thousand Oaks
IPO Date 2024-06-26
Ticker Symbols
| Name | Symbol |
|---|---|
| London | LLA.L |
More Shares
Investors who hold LLA.L,0P0001T9GN,0 also have the following shares in their portfolio:
